Meet the Editorial Staff

Tuesday, November 16, 2021

Our introductions continue and conclude this week. These staff are the core editorial team—the writers, editors, and advisers who produce a variety of articles and oversee the administrative functions of Poster. Whether they’re in the office or working remotely, they’re available to cover the research, operations, events, and people of NCI at Frederick and Frederick National Laboratory. Read on to meet them.

Tags:

Meet the Contributing Writers

Tuesday, November 9, 2021

As we begin the 2022 fiscal year and prepare to enter calendar year 2022, we on the editorial team want to take a moment to introduce ourselves to you. First up are our contributing writers, staff in program areas around our institutions who pitch ideas and cover topics related to those groups. Read on to meet them.

Tags:

Though Rare, HIV Leads to Blood Cancers

Wednesday, October 13, 2021

HIV plays a direct role in causing blood cell cancers in rare instances, says a new study of HIV and tumor DNA. Scientists have long known that HIV contributes to several cancers by weakening the immune system’s ability to fend off cancer-causing infections. However, this latest study, published in Science Advances this week, is the first to demonstrate HIV as a cause.

Tags:

It’s Time for a Flu Shot! Here’s What You Need to Know.

Photo of a nurse administering a vaccine to a man outside

Tuesday, October 12, 2021

With all the talk around COVID-19 vaccines and boosters, it's easy to forget there's another infectious respiratory disease already looming: influenza. Flu season is going to look a little different this year, according to Sarah Hooper, nurse practitioner (CRNP), RN, manager of the Frederick National Laboratory Occupational Health Services.

Tags:

Manufacturing and Quality Assurance Expertise by Frederick National Laboratory Supports NCI’s Pioneering Cancer Immunotherapy Program

Photo of a female scientist working in a lab

Thursday, September 23, 2021

A grim statistic is driving Steven Rosenberg’s mission to find new cancer treatments—and his partnership with Frederick National Laboratory to do so. “Every year in the United States, about 600,000 people die of cancer, 90% of whom die of the solid epithelial cancers,” said Rosenberg, the M.D., Ph.D., chief of the National Cancer Institute’s Surgery Branch, head of the Tumor Immunology Section at NCI’s Center for Cancer Research.

Tags: